2019 meeting of the global virus network

Ramesh Akkina; Robert Garry; Christian Bréchot; Heinz Ellerbrok; Hideki Hasegawa; Luis Menéndez-Arias; Natalia Mercer; Johan Neyts; Victor Romanowski; Joaquim Segalés; Anders Vahlne

doi:10.1016/j.antiviral.2019.104645

2019 meeting of the global virus network

Antiviral Res. 2019 Dec:172:104645. doi: 10.1016/j.antiviral.2019.104645. Epub 2019 Nov 4.

Authors

Affiliations

¹ Colorado State University. Microbiology, Immunology and Pathology, USA.
² Tulane University, New Orleans, LA, USA.
³ Global Virus Network, Baltimore, MD, USA.
⁴ Robert Koch Institute. Center for International Health Protection, Germany.
⁵ National Institute of Infectious Diseases. Department of Pathology, Japan.
⁶ Centro de Biología Molecular Severo Ochoa, Spain.
⁷ Rega Institute for Medical Research, University of Leuven, Belgium.
⁸ Universidad Nacional de La Plata. IBBM, Facultad de Ciencias Exactas, Argentina.
⁹ Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, and Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), UAB, Bellaterra, Spain.
¹⁰ Karolinska Institutet, Stockholm, Sweden; Global Virus Network, Baltimore, MD, USA. Electronic address: Anders.Vahlne@ki.se.

Abstract

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 52 GVN Centers of Excellence and 9 Affiliate laboratories in 32 countries. The 11th International GVN meeting was held from June 9-11, 2019 in Barcelona, Spain and was jointly organized with the Spanish Society of Virology. A common theme throughout the meeting was globalization and climate change. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including severe virus epidemics, anticipation and preparedness for changing disease dynamics, host-pathogen interactions, zoonotic virus infections, ethical preparedness for epidemics and pandemics, one health and antivirals.

Keywords: Climate change; Emerging viruses; Global virus network; Globalization; Pandemic.

Publication types

Review

MeSH terms

Animals
Antiviral Agents
Arboviruses / drug effects
Arboviruses / genetics
Arboviruses / metabolism
Climate Change
Communicable Diseases, Emerging* / drug therapy
Communicable Diseases, Emerging* / epidemiology
Communicable Diseases, Emerging* / transmission
Coronavirus / drug effects
Coronavirus / genetics
Coronavirus / metabolism
Ebolavirus / drug effects
Ebolavirus / genetics
Ebolavirus / metabolism
Global Health*
Hemorrhagic Fever, Ebola / drug therapy
Hemorrhagic Fever, Ebola / prevention & control
Hepatitis B / drug therapy
Hepatitis B / epidemiology
Hepatitis B / prevention & control
Host-Pathogen Interactions
Humans
Influenza, Human / drug therapy
Influenza, Human / epidemiology
Influenza, Human / prevention & control
Internationality
One Health / trends*
Pandemics
Viral Vaccines
Virus Diseases* / drug therapy
Virus Diseases* / epidemiology
Virus Diseases* / transmission
Viruses / drug effects
Viruses / genetics
Viruses / metabolism
Zoonoses / drug therapy
Zoonoses / epidemiology
Zoonoses / transmission

Substances

Antiviral Agents
Viral Vaccines